WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 1-Jun.-2018 (data as of 25-May-2018)
Next overall update Mid-July 2018
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 292
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 352

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 11  11  11  11  11  10 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years

Number of reported cases

(Click for retrospective incidence data for Nauru)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  300  10 
Mumps
ChartChart
 
Pertussis
ChartChart
  166 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Nauru)
Vaccine year result method % card seen                                                
BCG 2006  98  DHS   95  99*  99*  98  93 
DTP1 2006  98  DHS   95  99  98  80  85 
DTP3 2006  89  DHS   95  97  91  75  44 
DTP4          84  47  33 
IPV1          97  91  99* 
HepB_BD          99*  99*  98  98 
HepB3          97  91  95  58 
Hib3          97  91  75 
JapEnc         
MCV1          98  98  65 
MCV2          97  96  49 
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2006  91  DHS   95  97  91  75  27 
Rota1         
RotaC         
RCV1          98  98  65 
TT2plus          57  24 
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Nauru)
BCG
ChartChart
  99  99  99  99  93  93 
DTP1
ChartChart
  98  98  99  99  85  90 
DTP3
ChartChart
  91  91  95  87  44  74 
HepB3
ChartChart
  91  91  95  87  58 
HepB_BD
ChartChart
  99  99  99  99  98 
Hib3
ChartChart
  91  91  95  87 
IPV1
  91  91 
MCV1
ChartChart
  98  98  98  97 
MCV2
ChartChart
  96  96  94  88 
PCV3
 
Pol3
ChartChart
  91  91  95  87  27  74 
RCV1
ChartChart
  98  98  98  97 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.


Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaP 18 months; 4 years; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB_Pediatric birth; Yes
IPV 14 weeks; Yes
MR 12, 15 months; Yes
OPV 6, 10, 14 week; 18 months; 4 years; Yes
TT 1st contact; +4 weeks; +6 months; No

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR     No  No    No  No 
What years does the MYP cover? number              
Nº of districts with microplans that include activities to raise immunization coverage number              

System performance

Total Nº districts in country number   14    14   
Nº districts with DTP3 coverage >=80% number          
% of districts with DTP3 coverage >=80% From 0 to 100%           100   
Nº districts with measles (MCV1) coverage >=95% number            
% of districts with MCV1 coverage >=95% From 0 to 100%            

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND     No  No    No  No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR     No  No    No  No 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%     100        NA 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR     No  No    No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2018
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.